Assessment of response to treatment of unresectable liver tumours with y microspheres: value of fdg pet versus computed tomography

Nuclear Medicine Communications

Volumn 28, Issue 1, 2007, Pages 15-20

  Szyszko, Teresa ^a   AL Nahhas, Adil ^b   Canelo, Ruben ^b   Habib, Nagy ^b   Jiao, Long ^b   Wasan, Harpreet ^a   Pagou, Margarita ^a   Tait, Paul ^a  

^a Departments of Nuclear Medicine   (United Kingdom)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

FDG PET; Malignant liver tumours; Response to therapy

Indexed keywords

FLUORODEOXYGLUCOSE; MICROSPHERE; MICROSPHERE Y 90; TECHNETIUM 99M; YTTRIUM 90;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RADIOTHERAPY; CLINICAL ARTICLE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; LIVER CANCER; LIVER METASTASIS; MALE; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE DIAGNOSIS; RADIOACTIVITY; SELECTIVE INTERNAL RADIATION THERAPY; TUMOR VOLUME;

ADULT; COLORECTAL NEOPLASMS; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LIVER NEOPLASMS; MALE; MICROSPHERES; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; YTTRIUM RADIOISOTOPES;

EID: 33845671632     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328011453b     Document Type: Article

References (16)

1. Gray B, Van Hazel G, Hope M, Burton M, Moroz P, Anderson J, Gebshi V. Randomised trial of SIR spheres plus chemotherapy vs chemotherapy alone for treating patients with liver metastases from primary large bowel cancer. Ann Oncol 2001; 12:1711-1720.
2. 90ytrrium microspheres for extensive colorectal liver metastases. Hepatogastroenterology 2001; 48:333-337.
3. Taylor I, Bennett R, Sheriff S. The blood supply of colorectal liver metastases. Br J Cancer 1979; 39:749-756.
4. Van Hazel G, Blackwell A, Anderson J, Price D, Moroz P, Bower G, Cardaci G, Gray B, et al. Randomised phase 2 trial of SIR-spheres plus fluorouracil/leucovorin chemotherapy vs fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer. J Surg Oncol 2004; 8892:78-85.
5. 90Y microspheres. J Nucl Med 2000; 41:1673-1681.
6. Therasse P, Arbuck SG, Eisenhauer EA, Wanders J, Kaplan RS, Rubinstein L, et al. New guidelines to evaluate the response to treatment in solid tumors. J Natl Cancer Inst 2000; 92: 205-216.
7. 18F]FDG PET: a comparison with CT or MRI. Eur J Nucl Med Mol Imaging 2002; 29:815-820.
8. 18F]fluorodeoxyglucose positron emission tomographic imaging. J Vasc Interv Radiol 2005; 16:1101-1106.
9. Marn CS, Andrews JC, Francis IR, Hollett MD, Walker SC, Ensminger WD. Hepatic parenchymal changes after intraarterial Y-90 therapy: CT findings. Radiology 1993; 187:125-128.
10. Murthy R, Nunes R, Szklaruk J, Erwin W, Madoff DC, Gupta S, et al. Yttrium-90 microsphere therapy for hepatic malignancy:devices, indications, technical considerations and potential complications. Radiographics 2005; 25:S41-S55.
11. Coldwell D, Kennedy A. Treatment of unresectable nodular cholangiocarcinoma with yttrium-90 microspheres. Ann Oncol 2006; 17(suppl 6): vi56, abstract P102.
12. Popperl G, Helmberger T, Munzing W, Schmind R, Jacobs TF, Tasch K. Selective internal radiation therapy with SIR-spheres in patients with nonresectable liver tumours. Cancer Biother Radiopharm 2005; 20:200-208.
13. 18F-FDG uptake and tumour size on PET/CT. Eur J Nucl Med Mol Imaging 2005; 32:778-787.
14. 18F-FDG PET. J Nucl Med 2004; 45:1892-1897.
15. 90Y microsphere treatement for unresectable colorectal cancer metastases of the liver: response to treatment at targeted doses of 135-150 Gy as measured by FDG-PET and CT imaging. J Vasc Interv Radiol 2005; 16:1641-1651.
16. 90Y microspheres: dose ranging study. World J Nucl Med 2003; 2:216-225.